Publications by authors named "Jason G Weatherhead"

Claim this Profile
N
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.
Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, Eric E Boros, James B Thompson

Bioorg Med Chem Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).
Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, Teruhiko Taishi, David P Temelkoff

J Med Chem· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs.
Emile J Velthuisen, Todd M Baughman, Brian A Johns, David P Temelkoff, Jason G Weatherhead

Eur J Med Chem· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles.
Takashi Kawasuji, Brian A Johns, Hiroshi Yoshida, Jason G Weatherhead, Toshiyuki Akiyama

J Med Chem· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.
Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, Eric E Boros, James B Thompson

Bioorg Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.
Brian A Johns, Takashi Kawasuji, Jason G Weatherhead, Eric E Boros, James B Thompson

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo.
Christine Goffinet, Ina Allespach, Lena Oberbremer, Pamela L Golden, Scott A Foster, Jason G Weatherhead

J Virol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
Brian A Johns, Jason G Weatherhead, Scott H Allen, James B Thompson, Edward P Garvey

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
Brian A Johns, Jason G Weatherhead, Scott H Allen, James B Thompson, Edward P Garvey

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Edward P Garvey, Brian A Johns, Margaret J Gartland, Scott A Foster, Wayne H Miller, Jason G Weatherhead

Antimicrob Agents Chemother· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis